OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Pharmacology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors	323
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes	317
Planning experiments: Updated guidance on experimental design and analysis and their reporting III	292
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30	198
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets	187
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels	171
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors	149
Quercetin induces p53‐independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species‐dependent ferroptosis	132
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes	131
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters	115
Community guidelines for GPCR ligand bias: IUPHAR review 32	114
Astaxanthin ameliorates oxidative stress and neuronal apoptosis via SIRT1/NRF2/Prx2/ASK1/p38 after traumatic brain injury in mice	99
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors	97
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors	94
Nuciferine protects against folic acid‐induced acute kidney injury by inhibiting ferroptosis	92
Leonurine alleviates ferroptosis in cisplatin‐induced acute kidney injury by activating the Nrf2 signalling pathway	91
Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2‐mediated PI3K/Akt/mTOR signals	86
Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease	81
Osteosarcoma mechanobiology and therapeutic targets	80
Zebrafish as a tractable model of human cardiovascular disease	77
Unfractionated heparin inhibits live wild type SARS‐CoV‐2 cell infectivity at therapeutically relevant concentrations	73
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro	71
Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders	71
Clinical applications for exosomes: Are we there yet?	70
Review of delta‐8‐tetrahydrocannabinol (Δ⁸‐THC): Comparative pharmacology with Δ⁹‐THC	64

Triptolide prevents LPS‐induced skeletal muscle atrophy via inhibiting NF‐κB/TNF‐α and regulating protein synthesis/degradation pathway	62
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders	61
Eating microRNAs: pharmacological opportunities for cross‐kingdom regulation and implications in host gene and gut microbiota modulation	60
Acinar cell NLRP3 inflammasome and gasdermin D (GSDMD) activation mediates pyroptosis and systemic inflammation in acute pancreatitis	60
Mechanisms of enzalutamide resistance in castration‐resistant prostate cancer and therapeutic strategies to overcome it	60
The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets	59
Activation of thyroid hormone receptor‐β improved disease activity and metabolism independent of body weight in a mouse model of non‐alcoholic steatohepatitis and fibrosis	59
Transcriptome‐level discovery of survival‐associated biomarkers and therapy targets in non‐small‐cell lung cancer	56
Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment	55
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors	54
Omega‐3 polyunsaturated fatty acids and hypertension: a review of vasodilatory mechanisms of docosahexaenoic acid and eicosapentaenoic acid	54
Macrophage extracellular traps aggravate iron overload‐related liver ischaemia/reperfusion injury	54
Short‐chain fatty acids regulate B cells differentiation via the FFA2 receptor to alleviate rheumatoid arthritis	53
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats	51
Novel drug developmental strategies for treatment‐resistant depression	51
Sphingolipid metabolism during Toll‐like receptor 4 (TLR4)‐mediated macrophage activation	48
Soluble GC stimulators and activators: Past, present and future	47
The Concise Guide to PHARMACOLOGY 2023/24: Transporters	47
Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments	46
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer	46
The anomalous pharmacology of fentanyl	46
Complement, inflammation and thrombosis	46
The STING antagonist H‐151 ameliorates psoriasis via suppression of STING/NF‐κB‐mediated inflammation	46
Honokiol ameliorates cisplatin‐induced acute kidney injury via inhibition of mitochondrial fission	46